CHMP meeting highlights – January 2023
European Pharmaceutical Review
JANUARY 30, 2023
In its first meeting of 2023, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended four new medicines for approval, providing positive opinions for two type 2 diabetes drugs.
Let's personalize your content